@winshipcancer.emory.edu
As Georgia’s only NCI-Designated Comprehensive Cancer Center, we are dedicated to the prevention, treatment and control of cancer. #WhereScienceBecomesHope
@winshipcancer.emory.eduOn October 3, the 2026 Winship 5K Run/Walk celebrated its 16th anniversary with 3,900 participants and raised over $1 million to support cancer research and care at Winship.
@winshipcancer.emory.eduA first for Georgia. 🎗️🩷
Winship breast surgical oncologist Clara Farley, MD, has performed Georgia’s first robotic nipple-sparing mastectomy outside a clinical trial, bringing a new minimally invasive surgical option to select patients with breast cancer. https://bit.ly/47u3QcI
@winshipcancer.emory.eduWinship medical oncologist Neil Iyengar, MD, comments on a new FDA approved breast cancer treatment for patients with ESR1 mutations. https://www.healthline.com/health-news/fda-approves-eli-lilly-oral-combo-drug-common-breast-cancer-mutation
@winshipcancer.emory.eduComing up this week! Join us Sept. 19 for the Atlanta Breast Cancer Conference, co-chaired by Winship experts Kevin Kalinsky, MD, MS; Tari King, MD; and Reshma Jagsi, MD, DPhil.
There’s still time to register! Learn more ➡️ https://bioascend.com/atlanta-breast
@winshipcancer.emory.eduA new MRI approach made tiny lung tumors and early signs of cancer spread more visible in animal models, including several small lesions that CT scans failed to detect. 🔗 https://bit.ly/4r1LNUv
@winshipcancer.emory.eduMore than 260 nursing professionals from across the region attended Winship's 17th Annual Oncology Nursing Symposium on Aug. 21-22, gaining practical insights into emerging trends and evidence-based cancer care.
Learn more ➡️ https://bit.ly/4d4SDme
@winshipcancer.emory.eduWinship medical oncologist Neil Iyengar, MD, shares factors that may help reduce the risk of breast cancer recurrence and support long-term health after treatment.
Read more ➡️ https://bit.ly/4gwJjtB
@onclive.bsky.socialReposted by @winshipcancer.emory.eduAn evolving understanding of resistance mechanisms is shaping ROS1-positive NSCLC care, according to @latinamd.bsky.social and other experts. @winshipcancer.emory.edu @danafarber.bsky.social @moffittnews.bsky.social #lcsm #oncology
Read the full story ➡️: www.onclive.com/view/compreh...
@winshipcancer.emory.eduWinship Cancer Institute of Emory University launches the Cellular Therapy Initiative to accelerate next-generation cancer treatments through research, manufacturing and clinical trials.
Learn more ➡️ https://bit.ly/3Uv2ZFE.
